Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cardiovascular Institute of the South (CIS) is a comprehensive cardiovascular facility that integrates advanced clinical care with a world-class clinical research program. Founded in 1983 by Dr. Craig Walker, the institute has grown into one of the largest and most respected cardiology practices in the United States. The CIS Clinical Research department participates in numerous international Phase I-IV clinical trials, evaluating innovative medical devices, pharmacological treatments, and interventional techniques. Their research focus spans a wide array of conditions, including peripheral artery disease, coronary artery disease, heart failure, and structural heart defects. By serving as a high-volume enrollment site for pivotal studies, CIS provides patients with access to cutting-edge therapies before they reach the general market. The organization is recognized globally for its contributions to medical literature and its role in the development of new standards of care in vascular medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cardiovascular Institute of the South Clinical Research.